Albumin-Bound Paclitaxel In Metastatic Breast CancerA Viewpoint by Nuhad Ibrahim

被引：0
|
作者：
Nuhad Ibrahim
机构：
[1] The University of Texas,MD Anderson Cancer Center
来源：
Drugs | 2006年 / 66卷 / 7期
关键词：
Paclitaxel; Metastatic Breast Cancer; Tumour Microvasculature; Tumour Interstitium; SPARC Expression;
D O I：
10.2165/00003495-200666070-00009
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：949 / 949
相关论文
共 50 条
  • [21] Safety and efficacy evaluation of albumin-bound paclitaxel
    Cecco, Sara
    Aliberti, Maria
    Baldo, Paolo
    Giacomin, Elisa
    Leone, Roberto
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (04) : 511 - 520
  • [22] Cost-effectiveness of nanoparticle albumin-bound paclitaxel versus docetaxel in the treatment of metastatic breast cancer.
    Gradishar, W
    Vishalpura, T
    Franklin, M
    Bramley, T
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S220 - S221
  • [23] A phase II study of weekly nanoparticle albumin-bound paclitaxel combined with cisplatin in patients with metastatic breast cancer
    Wang, Biyun
    Hu, Xi-Chun
    Sun, Si
    Zhang, Jian
    Tang, Lichen
    Wang, Zhong Hua
    Wang, Lei Ping
    Lv, Fangfang
    Zhang, Qunling
    Zheng, Chunlei
    Jia, Zhen
    Lu, Yunhua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer
    Ibrahim, NK
    Samuels, B
    Page, R
    Doval, D
    Patel, KM
    Rao, SC
    Nair, MK
    Bhar, P
    Desai, N
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6019 - 6026
  • [25] Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Metastatic Breast Cancer: A Meta-Analysis
    Li, Xin
    Kwon, Hyungju
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [26] Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer
    Cortes, Javier
    Saura, Cristina
    EJC SUPPLEMENTS, 2010, 8 (01): : 1 - 10
  • [27] Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
    Li, Qingmei
    Zhang, Hong
    Zhu, Xiaoxue
    Liu, Chengjiao
    Wu, Min
    Li, Cuiyun
    Li, Xiaojiao
    Gao, Lei
    Ding, Yanhua
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [28] SAFETY OF WEEKLY ADMINISTRATION OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL IN PATIENTS WITH BREAST CANCER
    Seki, H.
    Asanuma, F.
    Yamada, Y.
    Hirata, Y.
    Kaneda, M.
    Suzuki, K.
    Osaku, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E41 - E41
  • [29] Paclitaxel in Early Breast CancerA Viewpoint by David A. Cameron
    David A. Cameron
    Drugs, 2004, 64 : 1848 - 1849
  • [30] BUDGET IMPACT OF ALBUMIN-BOUND PACLITAXEL plus GEMCITABINE IN THE TREATMENT OF METASTATIC PANCREATIC CANCER
    Binder, G.
    Whiting, S.
    Milentijevic, D.
    Penenberg, D.
    Wei, X.
    Kayitalire, L.
    Renschler, M. F.
    VALUE IN HEALTH, 2014, 17 (03) : A74 - A74
12345